Skip to main content

Bausch Health, formerly known as Valeant Pharmaceuticals, shares jump after raising 2019 outlook

Bausch Health, formerly known as Valeant Pharmaceuticals, is slated to report first-quarter earnings before Wall Street's open on Monday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.